These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 39109010)

  • 21. Serum Prealbumin Improves the Sensitivity of Pneumonia Severity Index in Predicting 30-day Mortality of CAP Patients.
    Zhang HF; Li LQ; Ge YL; Zhang JB; Fu AS; Liu CH; Shao DF; Bai J; Zhu XY
    Clin Lab; 2020 May; 66(5):. PubMed ID: 32390376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Midregional proadrenomedullin as a prognostic tool in community-acquired pneumonia.
    Huang DT; Angus DC; Kellum JA; Pugh NA; Weissfeld LA; Struck J; Delude RL; Rosengart MR; Yealy DM
    Chest; 2009 Sep; 136(3):823-831. PubMed ID: 19363212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multimarker Prognostication for Hospitalized Patients with Community-acquired Pneumonia.
    Yeon Lee S; Cha SI; Seo H; Oh S; Choi KJ; Yoo SS; Lee J; Lee SY; Kim CH; Park JY
    Intern Med; 2016; 55(8):887-93. PubMed ID: 27086800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Longitudinal associations between serum IL-34 with severity and prognosis in community-acquired pneumonia patients.
    Tang F; Hou XF; Cheng Y; Liu Y; Sun J; Liu HY; Lv LP; Fu L
    Respir Investig; 2024 Mar; 62(2):223-230. PubMed ID: 38218098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cold-inducible RNA-binding protein might determine the severity and the presences of major/minor criteria for severe community-acquired pneumonia and best predicted mortality.
    Guo Q; Song WD; Li HY; Li M; Chen XK; Liu H; Peng HL; Yu HQ; Liu N; Lü ZD; Liang LH; Zhao QZ; Jiang M
    Respir Res; 2020 Jul; 21(1):192. PubMed ID: 32689999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic Value of Histidine-Rich Glycoprotein for Community-Acquired Pneumonia.
    He X; Luo Q; Zhao L; Shang Y; Gao Z
    Dis Markers; 2022; 2022():4713045. PubMed ID: 35154511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum Level of 4-Hydroxynonenal in Community-Acquired Pneumonia: A Potential Biomarker for Severity and Prognosis.
    Jiang YL; Liu HY; Tang MM; Cheng JY; Zhao H; Fu L
    Front Med (Lausanne); 2022; 9():798343. PubMed ID: 35783645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum 8-Hydroxydeoxyguanosine Is a Potential Indicator for the Severity and Prognosis in Patients with Community-Acquired Pneumonia: A Prospective Cohort Study.
    Cao LF; Cheng JY; Xu Z; Feng CM; Zhao H; Wang XM; Fu L
    J Immunol; 2022 Jan; 208(2):321-327. PubMed ID: 34911771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Associations of Serum Resistin With the Severity and Prognosis in Patients With Community-Acquired Pneumonia.
    Feng CM; Cheng JY; Xu Z; Liu HY; Xu DX; Fu L; Zhao H
    Front Immunol; 2021; 12():703515. PubMed ID: 34858392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combining a Frailty Index Based on Laboratory Data and Pneumonia Severity Assessments to Predict In-Hospital Outcomes in Older Adults with Community-Acquired Pneumonia.
    Zan YM; Zheng TP; Wang Y; Shao JF; Wang ZY; Zhao WH; Wu JQ; Xu W
    J Nutr Health Aging; 2023; 27(4):270-276. PubMed ID: 37170434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk stratification and prediction value of procalcitonin and clinical severity scores for community-acquired pneumonia in ED.
    Zhou H; Guo S; Lan T; Ma S; Zhang F; Zhao Z
    Am J Emerg Med; 2018 Dec; 36(12):2155-2160. PubMed ID: 29691103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Admission Pentraxin-3 Level Predicts Severity of Community-Acquired Pneumonia Independently of Etiology.
    Luo Q; He X; Ning P; Zheng Y; Yang D; Xu Y; Shang Y; Gao Z
    Proteomics Clin Appl; 2019 Jul; 13(4):e1800117. PubMed ID: 30557448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longitudinal associations of serum survivin with the severity and prognosis of community-acquired pneumonia patients.
    Cheng JY; Tang MM; Fang P; Liu Y; Sun J; He QY; Deng YP; Hou XF; Zhao H; Fu L
    Respir Investig; 2023 Jan; 61(1):84-94. PubMed ID: 36336629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Yield of two mortality predictors in immunocompetent patients with community acquired pneumonia].
    Muñoz P; Garmendia ML; Ruiz M; Pizarro R; Rossi P; Prades Y; Huenchur L; Lizama L; Ampuero S; Larrañaga C; Avendaño LF; Luchsinger V
    Rev Med Chil; 2021 Sep; 149(9):1275-1284. PubMed ID: 35319680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Usefulness of procalcitonin levels in community-acquired pneumonia according to the patients outcome research team pneumonia severity index.
    Masiá M; Gutiérrez F; Shum C; Padilla S; Navarro JC; Flores E; Hernández I
    Chest; 2005 Oct; 128(4):2223-9. PubMed ID: 16236878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Prospective Study of Presepsin as an Indicator of the Severity of Community-Acquired Pneumonia in Emergency Departments: Comparison with Pneumonia Severity Index and CURB-65 Scores.
    Ham JY; Song KE
    Lab Med; 2019 Oct; 50(4):364-369. PubMed ID: 30892617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma Monocyte Chemoattractant Protein-1 Level as a Predictor of the Severity of Community-Acquired Pneumonia.
    Yong KK; Chang JH; Chien MH; Tsao SM; Yu MC; Bai KJ; Tsao TC; Yang SF
    Int J Mol Sci; 2016 Jan; 17(2):. PubMed ID: 26840299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunoglobulins concentration and B cell counts as severity markers in adult community-acquired pneumonia: Cross sectional study.
    Luchsinger V; Lizama L; Garmendia ML; Tempio F; Ruiz M; Pizarro R; Rossi P; Huenchur L; Moreno C; López M; Ampuero S; Larrañaga C; Avendaño LF
    Medicine (Baltimore); 2020 Nov; 99(45):e22390. PubMed ID: 33157914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic factors in hospitalized community-acquired pneumonia: a retrospective study of a prospective observational cohort.
    Ito A; Ishida T; Tokumasu H; Washio Y; Yamazaki A; Ito Y; Tachibana H
    BMC Pulm Med; 2017 May; 17(1):78. PubMed ID: 28464807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive values of semi-quantitative procalcitonin test and common biomarkers for the clinical outcomes of community-acquired pneumonia.
    Ugajin M; Yamaki K; Hirasawa N; Yagi T
    Respir Care; 2014 Apr; 59(4):564-73. PubMed ID: 24170911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.